Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced Diabetes
Authors:
Open Access
- 7 October 2016
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 66 (1) , 45-57
Abstract
Heparanase, a protein with enzymatic and nonenzymatic properties, contributes toward disease progression and prevention. In the current study, a fortuitous observation in transgenic mice globally overexpressing heparanase (hep-tg) was the discovery of improved glucose homeostasis. We examined the mechanisms that contribute toward this improved glucose metabolism. Heparanase overexpression was associated with enhanced glucose-stimulated insulin secretion and hyperglucagonemia, in addition to changes in islet composition and structure. Strikingly, the pancreatic islet transcriptome was greatly altered in hep-tg mice, with >2,000 genes differentially expressed versus control. The upregulated genes were enriched for diverse functions including cell death regulation, extracellular matrix component synthesis, and pancreatic hormone production. The downregulated genes were tightly linked to regulation of the cell cycle. In response to multiple low-dose streptozotocin (STZ), hep-tg animals developed less severe hyperglycemia compared with wild-type, an effect likely related to their β-cells being more functionally efficient. In animals given a single high dose of STZ causing severe and rapid development of hyperglycemia related to the catastrophic loss of insulin, hep-tg mice continued to have significantly lower blood glucose. In these mice, protective pathways were uncovered for managing hyperglycemia and include augmentation of fibroblast growth factor 21 and glucagon-like peptide 1. This study uncovers the opportunity to use properties of heparanase in management of diabetes.Keywords
Funding Information
- Canadian Institutes of Health Research (CIHR-MOP-133547)
This publication has 46 references indexed in Scilit:
- Heparanase and Autoimmune DiabetesFrontiers in Immunology, 2013
- Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple MyelomaJournal of Biological Chemistry, 2012
- Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetesJournal of Clinical Investigation, 2012
- Heparanase-mediated Loss of Nuclear Syndecan-1 Enhances Histone Acetyltransferase (HAT) Activity to Promote Expression of Genes That Drive an Aggressive Tumor PhenotypeJournal of Biological Chemistry, 2011
- Full-length transcriptome assembly from RNA-Seq data without a reference genomeNature Biotechnology, 2011
- Acute Insulin Signaling in Pancreatic Beta-Cells Is Mediated by Multiple Raf-1 Dependent PathwaysEndocrinology, 2010
- Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet FunctionDiabetes, 2009
- Developmental biology of the pancreas: A comprehensive reviewDevelopmental Biology, 2009
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in MyelomaJournal of Biological Chemistry, 2008
- Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?Trends in Molecular Medicine, 2002